Root Financial Partners’s Prime Medicine PRME Stock Holding History

Root Financial Partners’s Portfolio PRME Stock Details PRME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$306	Buy	+100	New	+$332	﹤0.01%	3401

Other funds holding PRME

Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $17.4B AUM 41.01% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Nikko Asset Management Americas New York $8.04B AUM 33.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Root Financial Partners's PRME Position: Q3 2026 in Review

Root Financial Partners opened a new position in Prime Medicine (PRME) in Q3 2026: 100 shares worth $306. The stake represents ﹤0.01% of the portfolio and ranks #3401 among its holdings.

125 funds tracked by Wall St. Rank hold PRME as of Q3 2026.

Root Financial Partners held 100 shares of Prime Medicine worth $306 as of Q3 2026.
Prime Medicine was a new Root Financial Partners position in Q3 2026.
Prime Medicine made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3401 holding.
125 funds tracked by Wall St. Rank held Prime Medicine as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.